| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |